USFDA Issues 9 Observations to Aurobindo’s Jedcherla Unit-VII After Inspection
New Delhi: Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its Unit-VII manufacturing facility located at Jedcherla in Telangana.…